Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lifestyle makeover may keep seniors on their feet

NCT ID NCT02082171

Prevention Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This pilot study tested a personalized program combining physical activity, cognitive training, and nutritional advice in 210 older adults who were frail or pre-frail. The goal was to see if this multidomain approach could prevent mobility disability, measured by the ability to walk 400 meters. The results will help design a larger, definitive trial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multidomain lifestyle intervention (physical activity, cognitive training, nutritional modifications)
What this could lead to
If successful, this could point toward an effective way to prevent older adults from losing their ability to walk and stay independent.
What could go wrong
This is a small pilot study with only 210 participants, so results may not apply to everyone. The intervention is complex and may be hard to stick with long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

210 people

The number who actually took part.

Started

Oct 2013

Finished

Jan 2016

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age of 60 years and older; * Willingness to be randomized to either treatment group; * Pre-frailty or frailty status according to the phenotype described by Fried and colleagues Exclusion Criteria: * Failure to provide informed consent; * Inability to complete a 400-meter walk test (primary outcome of the study); * Living in nursing home; * Living outside of the area of interest, or planning to move out of the area in next 3 years, or planning to leave the area for more than 3 months during the next year; * Relevant cognitive impairment (defined as a known diagnosis of dementia); * Severe progressive, degenerative neurologic disease (e.g., multiple sclerosis); * Severe rheumatologic or orthopaedic diseases (e.g., awaiting joint replacement); * Terminal illness with life expectancy less than 12 months; * Severe pulmonary disease (e.g., oxygen therapy or chronic use of steroids); * Severe cardiac disease (e.g., New York Heart Association Class III or IV heart failure, clinically significant aortic stenosis, history of cardiac arrest, uncontrolled angina); * Other significant comorbid conditions that would impair the ability to participate in the multidomain intervention (e.g., renal failure on hemodialysis, severe psychiatric disorder, excessive alcohol use). To be noted: persons with depression will not be excluded.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mobility disability are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mobility disability Physical disability Physical frailty

Contacts and locations

Locations

  • Centre de Rééducation Fonctionnelle "La Roseraie"

    Montfaucon, 46240, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.